Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Coadministered with Quadrivalent Influenza Vaccine: A Phase 3 Randomized Trial
Vaccine(2023)
Key words
20-valent pneumococcal conjugate vaccine,Coadministration,Immunogenicity,Influenza,Safety,Streptococcus pneumoniae
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined